Market News

3 Stocks That Are Set for Monster Growth in 2022

0

American City Business Journals

Viatris keen to increase dividends

Canonsburg-based drug manufacturer Viatris Inc. said its initial return to shareholders in 2022 will come in the form of dividends, with CEO Michael Goettler not completely shutting the door on stock buybacks but saying the latter was a more complex issue. Viatris (NYSE: VTRS), which will turn a year old next week, is the combination of Mylan NV and the Upjohn unit of Pfizer Inc. (NYSE: PFE). Viatris had earnings of $311.5 million, 26 cents a share, on revenue of $4.5 billion, compared to $185.7 million, 36 cents a share, on revenue of $2.9 million for Mylan and Upjohn a year ago.

The stock market has rallied past just about every 2021 forecast from Wall Street’s top strategists

Previous article

The No. 1 reason to buy index funds

Next article

You may also like

Comments

Leave a reply

Your email address will not be published.

More in Market News